世界の低侵襲性脳神経外科用機器市場の規模、シェア、トレンド分析レポート – 業界概要と2032年までの予測

Get Exclusive Sample PDF of this Report Here

低侵襲性脳神経外科機器市場分析

低侵襲性脳神経外科用デバイス市場は、技術の進歩と低侵襲性処置の需要増加に牽引され、大幅な成長を遂げています。低侵襲技術は、回復時間の短縮、手術リスクの低減、入院期間の短縮などの利点があるため好まれています。強化された画像システム、ロボット支援手術ツール、改良されたナビゲーションおよび視覚化デバイスなどの医療技術の進歩は、この分野に革命をもたらし、より正確な処置とより良い患者の転帰を可能にしました。企業は、高度な内視鏡システム、神経ナビゲーションツール、手術用ロボットなどの最先端デバイスの開発に多額の投資を行い、健康な組織への破壊を最小限に抑えながら複雑な神経学的状態に対応しています。低侵襲処置は、従来の開腹手術に比べて有効性と合併症率の低さから、脊椎、頭蓋、神経血管の処置を含むさまざまな手術でますます使用されています。市場はまた、医療費を削減する患者中心のケアと費用対効果の高いソリューションへの注目の高まりによって支えられています。継続的な技術革新と、神経血管疾患にかかりやすい世界人口の高齢化により、市場は拡大し続けると予測されており、新規参入者と既存プレーヤーに製品ポートフォリオを開発および拡大する機会が提供されます。

低侵襲性脳神経外科用機器市場規模

世界の低侵襲性脳神経外科用機器の市場規模は、2024年に20億米ドルと評価され、2025年から2032年の予測期間中に6.02%のCAGRで成長し、2032年までに31億9,000万米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

低侵襲性脳神経外科用機器の市場動向

「ロボット支援手術システムの統合」

低侵襲性脳神経外科用デバイス市場における重要なトレンドの 1 つは、ロボット支援手術システムの統合です。これにより、複雑な手術の精度と効率が向上します。メドトロニックやブレインラボが開発したロボット システムにより、外科医は繊細な手術をより正確に実行できるようになり、合併症のリスクが軽減され、患者の転帰が改善されます。これらのシステムはリアルタイムの視覚化と高度なナビゲーション機能を提供するため、脊椎手術や神経血管手術に非常に役立ちます。たとえば、メドトロニックの Stealth Autoguide システムは、脳神経外科医が手術計画を立て、ピンポイントの精度で器具を誘導するのに役立ちます。このトレンドは、侵襲性を最小限に抑えることを重視する業界の姿勢と一致しており、これにより回復時間が短縮され、術後合併症が減少します。ロボット テクノロジーの採用が拡大しているのは、患者ケアの向上をサポートする高精度ツールの需要が高まっていることを反映しており、医療部門のイノベーションと手術結果の改善の推進と一致しています。

レポートの範囲と低侵襲性脳神経外科用機器市場のセグメンテーション

Get Exclusive Sample PDF of this Report Here

低侵襲性脳神経外科用機器市場の定義

低侵襲性脳神経外科用機器とは、周囲の組織への損傷を最小限に抑えながら神経系に外科手術を施すために設計された特殊な医療機器および技術を指します。これらの機器により、脳神経外科医は小さな切開または特殊な技術を使用して脳、脊椎、末梢神経系の領域にアクセスして治療することができ、従来の開腹手術と比較して感染のリスクが軽減され、回復時間が短縮され、術後の痛みが最小限に抑えられます。

低侵襲性脳神経外科用機器市場の動向

ドライバー

• 神経疾患の増加

神経疾患の罹患率の上昇は、低侵襲性脳神経外科用デバイス市場の大きな推進力となっています。神経血管疾患、脊椎疾患、脳関連疾患などの発症率の上昇により、効果的な外科的治療の必要性が高まり続けているためです。たとえば、世界保健機関 (WHO) によると、世界中で約 5,000 万人がてんかんという一般的な神経疾患に苦しんでおり、脳卒中は依然として世界の主要な死亡原因の 1 つです。さらに、椎間板ヘルニアや脊柱管狭窄症などの疾患につながる高齢化や座りがちな生活習慣などの要因により、脊椎手術の件数が急増しています。この外科的介入の需要の高まりにより、従来の手術と比較して患者の転帰が改善され、回復時間が短縮され、合併症のリスクが低くなるため、高度な低侵襲技術の採用が促進されています。その結果、神経疾患の罹患率は引き続き市場の成長を後押しし、革新的な外科的ソリューションの開発と使用を促しています。

• 高齢化人口の増加

The increasing geriatric population is a major driver for the minimally invasive neurosurgical devices market, as older adults are more susceptible to neurological disorders and conditions that require surgical intervention. According to the United Nations, the global population aged 60 years and over is expected to reach 2.1 billion by 2050, up from 1 billion in 2020, highlighting the rapid growth of the elderly demographic. This age group is particularly prone to conditions such as spinal disorders, neurovascular diseases, and degenerative brain conditions that often necessitate surgery. Minimally invasive neurosurgical techniques are particularly appealing for treating the elderly, as they involve less trauma, faster recovery, and reduced risk of complications, which aligns with the medical needs and preferences of this population. Consequently, the expanding elderly population is fueling demand for safer, more efficient surgical solutions, driving growth in the market for minimally invasive neurosurgical devices.

Opportunities

• Increasing Advancements in Technology

Advancements in technology have created significant market opportunities in the minimally invasive neurosurgical devices market, as innovations in imaging systems, robotic-assisted surgical tools, and enhanced navigation and visualization devices have greatly improved the precision and efficiency of these procedures. For instance, advanced neuronavigation systems such as the Medtronic Stealth Autoguide and Brainlab's Curve systems allow neurosurgeons to accurately map out surgical paths and make real-time adjustments, minimizing risk and enhancing patient outcomes. The integration of 3D imaging and augmented reality in surgical planning further enables more precise targeting and reduces the need for large incisions. In addition, robotic surgery, such as the use of the Mazor X Stealth Edition by Medtronic, has introduced greater control and accuracy to complex procedures. These technological advancements drive improved surgical results and expand the scope of procedures that can be performed using minimally invasive techniques, creating significant growth opportunities within the market.

• Rising Government Initiatives and Investments

Government initiatives and investments are creating substantial opportunities in the minimally invasive neurosurgical devices market, as both public and private sectors increase their support for the development and adoption of advanced medical technologies. For instance, countries such as the U.S. have launched programs such as the National Institute of Neurological Disorders and Stroke (NINDS), which funds research and development for innovative neurosurgical solutions. Similarly, European Union grants and partnerships with healthcare institutions encourage the creation of state-of-the-art medical devices, contributing to advancements in surgical techniques and patient care. Private sector investments are also on the rise, with companies such as Medtronic and Brainlab channeling substantial resources into R&D to push the boundaries of minimally invasive procedures. This combined push from both governmental bodies and private enterprises supports a robust innovation cycle, leading to the development of new, more effective neurosurgical devices and driving market growth.

Restraints/Challenges

• High Costs of Minimally Invasive Neurosurgical Devices

High costs present a significant challenge in the minimally invasive neurosurgical devices market, potentially limiting their adoption and accessibility, especially in regions with budget constraints or lower-income healthcare systems. The development and manufacturing of advanced neurosurgical devices involve significant investment in research, materials, precision engineering, and regulatory compliance, which can drive up prices. For instance, high-tech imaging systems and robotic-assisted surgical devices are costly to produce and maintain. In countries with constrained healthcare budgets, hospitals and surgical centers may find it difficult to justify the expense of incorporating these devices, opting instead for more traditional and less costly methods. This can create a gap in access to cutting-edge medical treatments, impacting patient outcomes and overall market growth. The challenge of high costs emphasizes the need for strategies that make advanced devices more affordable, such as partnerships between manufacturers and healthcare providers, public-private funding, or tiered pricing models that can cater to different economic conditions.

• Patient Safety and Complications

Patient safety and complications remain a crucial challenge in the minimally invasive neurosurgical devices market, despite their benefits of shorter recovery times and reduced hospital stays. Although these procedures are designed to minimize disruption to surrounding tissues and lower the risk of complications compared to traditional open surgeries, the potential for adverse outcomes such as infections, bleeding, or damage to surrounding neural structures still exists. For instance, complications from minimally invasive spine surgeries, such as inadvertent nerve injury, can lead to long-term disability and negatively impact patient trust in these advanced techniques. Managing these risks effectively requires continuous innovation in device design, rigorous training for surgeons, and stringent quality control processes, all of which add to the complexity and cost of bringing these devices to market. Failure to ensure high patient safety standards can erode trust, hinder adoption, and slow the growth of the market. This challenge underscores the need for ongoing advancements in device technology, comprehensive surgical training programs, and robust post-operative monitoring to mitigate risks and improve patient outcomes.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Minimally Invasive Neurosurgical Devices Market Scope

The market is segmented on the basis of product, surgery type, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Surgical Devices
• Monitoring and Visualization Devices
• Endoscopy Devices

Surgery Type

• Endonasal Neurosurgery
• Intracranial Surgery
• Spinal Surgery
• Others

End User

• Hospital
• Clinics
• Medical Institution
• Ambulatory Surgical Center

Minimally Invasive Neurosurgical Devices Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product, surgery type, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the minimally invasive neurosurgical devices market, driven by the increasing prevalence of neurovascular diseases and the growing awareness among neurosurgeons and medical professionals about the advantages of using advanced neurology devices. Europe holds the second-largest share in the market, propelled by comparable factors, such as the rising incidence of neurological disorders and the emphasis on modern surgical techniques. Both regions benefit from a strong presence of highly skilled surgeons and healthcare professionals, along with advanced medical infrastructure and well-established healthcare facilities. These factors collectively contribute to their dominance in the global market, showcasing their capacity to adopt and implement innovative surgical solutions effectively.

Asia-Pacific region is becoming an increasingly profitable market for minimally invasive neurosurgical devices from 2025 to 2032, driven by growing awareness about the benefits of these advanced medical devices and a rising population. In addition, government initiatives aimed at enhancing healthcare infrastructure and boosting medical investments are playing a crucial role in supporting market growth. The region's focus on improving medical access and quality of care is encouraging the adoption of innovative neurology technologies. This combination of factors positions Asia-Pacific as a key area for expansion in the minimally invasive neurosurgical devices market over the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Minimally Invasive Neurosurgical Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Minimally Invasive Neurosurgical Devices Market Leaders Operating in the Market Are:

• General Medical Inc. (U.S.)
• Stryker (U.S.)
• Zimmer Biomet (U.S.)
• B. Braun SE (Germany)
• Olympus Corporation (Japan)
• Renishaw plc. (U.K.)
• Medtronic (Ireland)
• Danaher (U.S.)
• ZEISS AG (Germany)
• KARL STORZ (Germany)
• Brainlab AG (Germany)
• Monteris (Canada)
• INTEGRA LIFESCIENCES (U.S.)
• Penumbra, Inc. (U.S.)
• Aesculap, Inc. (Germany)
• Boston Scientific Corporation (U.S.)
• Richard Wolf GmbH (Germany)
• Nico Corporation (U.S.)
• Soring GmbH (Germany)
• Vycor Medical Inc. (U.S.)
• CONMED Corporation (U.S.)
• Johnson & Johnson Services Inc. (U.S.)
• Microbot Medical Inc. (U.S.)

Latest Developments in Minimally Invasive Neurosurgical Devices Market

• In April 2024, Dr. Reddy’s launched Nerivio, a drug-free, noninvasive device for migraine management. Supported by the company's M-free patient support program, this device aims to enhance the patient experience with services including onboarding, counseling, device demonstrations, doorstep delivery, flexible payment plans, educational content, and dedicated customer support.
• In January 2023, PENTAX Medical received CE marks for its new premium video processor, the PENTAX Medical INSPIRA, and the i20c video endoscope series. This new processor is compatible with PENTAX Medical's latest endoscope models and introduces new standards for high-quality imaging.
• In August 2023, Orthofix Medical announced the full commercial launch of their 7D Flash navigation system percutaneous module 2.0 in the U.S.. This enhanced version adds new planning features and broadens the utility of the 7D Flash neuronavigation system for minimally invasive spinal surgeries. The 7D system was originally provided by 7D Surgical, which was acquired by SeaSpine in 2021 after the merger between Orthofix and SeaSpine earlier this year.
• In October 2022, scientists from Imperial College London successfully implanted a new bioinspired, flexible, and steerable device into the brains of living animals using a minimally invasive robotic system for the first time. This advanced platform offers high precision and less intrusive procedures and could potentially improve the detection and treatment of diseases in humans if proven safe and effective.
• 2022年6月、ボストン・サイエンティフィックは、内視鏡や泌尿器科手術に使用される非血管金属ステントの韓国の製造・販売会社であるMITechの過半数の株式を取得する契約を締結しました。この取引の価値は約2億3,000万ドルで、ボストン・サイエンティフィックはMITechの株式1株あたり約11ドルを支払いました。

SKU-62887